William JL Rieflin's Net Worth

$135 Thousand

Estimate Recalculated Nov 3, 2024 09:36PM EST

Who is William JL Rieflin?

William JL Rieflin does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals Inc, NGM BIOPHARMACEUTICALS INC, RAPT Therapeutics, Inc., Lyell Immunopharma, Inc., XENOPORT INC, and TULARIK INC.

SEC CIK

William JL Rieflin's CIK is 0001182471

Past Insider Trading and Trends

2010 was William JL Rieflin's most active year for acquiring shares with 9 total transactions. William JL Rieflin's most active month to acquire stocks was the month of April. 2016 was William JL Rieflin's most active year for disposing of shares, totalling 16 transactions. William JL Rieflin's most active month to dispose stocks was the month of July. 2020 saw William JL Rieflin paying a total of $162,200.00 for 92,500 shares, this is the most they've acquired in one year. In 2016 William JL Rieflin cashed out on 235,916 shares for a total of $1,045,380.05, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Anacor Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-89.85K
$99.25
-$8,917,910.25
0
Jun 24
Form 4
∞
89K
$8.33
$741,080.00
89K
Mar 31
Form 4
∞
853
—
—
853
Jun 9
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Mar 31
Form 3
—
0
—
—
0
No matching records found

NGM BIOPHARMACEUTICALS INC (NGM) No price found

Executive Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.77M
—
—
0
Apr 5
Form 4
—
0
—
—
0
May 10
Form 4
—
0
—
—
0
Mar 3
Form 4
—
0
—
—
0
Mar 17
Form 4
—
0
—
—
0
Feb 4
Form 4
+2.09%
56.67K
—
—
2.77M
Apr 8
Form 3
—
0
—
—
0
No matching records found

RAPT Therapeutics, Inc. (RAPT) Snapshot price: $1.83

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
Mar 28
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
May 28
Form 4
+125.00%
10K
$16.22
$162,200.00
18K
Nov 19
Form 4
—
0
—
—
0
Jun 18
Form 4
+408.35%
68.06K
$12.00
$96,000.00
84.72K
Nov 4
Form 4
—
0
—
—
0
Oct 30
Form 3
—
0
—
—
0
No matching records found

Lyell Immunopharma, Inc. (LYEL) Snapshot price: $1.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Sep 8
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 8
Form 3
—
0
—
—
0
No matching records found

XENOPORT INC No price found

President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-312.85K
$7.03
-$2,199,300.35
0
Jul 5
Form 4
+18.75%
5K
—
—
31.66K
May 17
Form 4
+23.08%
5K
—
—
26.66K
May 19
Form 4
-33.70%
-11.01K
$8.49
-$93,474.90
21.66K
Dec 10
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 11
Form 4
+18.07%
5K
—
—
32.67K
May 14
Form 4
+22.06%
5K
—
—
27.67K
May 14 - May 16
Form 4
—
0
—
—
0
May 16
Form 4
+3.69%
10K
$3.86
$38,580.00
281.12K
Dec 16
Form 4
+3.83%
10K
$4.44
$44,413.00
271.12K
Nov 21
Form 4
+1.95%
5K
$5.49
$27,451.50
261.12K
Nov 7
Form 4
—
0
—
—
0
May 11
Form 4
+1.76%
399
—
—
23.07K
Sep 16 - Sep 17
Form 4
—
0
—
—
0
May 13
Form 4
—
0
—
—
0
Mar 12
Form 4
+16.04%
2.92K
—
—
21.11K
Feb 24
Form 4
+7.38%
1.25K
—
—
18.19K
Feb 1
Form 4
—
0
—
—
0
Jan 13
Form 4
+9.91%
1.46K
—
—
16.19K
Feb 17
Form 4
+9.27%
1.25K
—
—
14.73K
Jan 28 - Jan 30
Form 4
+2.17%
5.59K
—
—
263.09K
Dec 15 - Jan 14
Form 4
+14.45%
18.89K
$15.00
$283,305.00
149.61K
Nov 10
Form 4
+25.05%
1.46K
—
—
7.28K
Feb 19
Form 4
—
0
—
—
230.67K
Dec 10 - Jan 30
Form 4
-1.17%
-2.79K
—
—
235.48K
Feb 27 - Apr 26
Form 4
—
0
—
—
0
Jan 30
Form 4
-1.30%
-3.15K
—
—
238.28K
Sep 15 - Nov 6
Form 4/A
+0.96%
2.27K
$8.93
$20,277.60
238.94K
Nov 16
Form 4
+0.85%
2.27K
$8.93
$20,277.60
268.94K
Nov 16 - Jan 31
Form 3
—
0
—
—
0
No matching records found